Bristol-Myers Squibb Company
HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT
Last updated:
Abstract:
Formulations of the HIV compounds atazanavir and cobicistat, and methods of treatment utilizing these formulations, are set forth.
Status:
Application
Type:
Utility
Filling date:
7 Aug 2019
Issue date:
28 Nov 2019